Collectively, these findings underscore the multifaceted roles of ACSL4, SAT2, and XBP1 in disease pathogenesis, particularly in ferroptosis and immune modulation, making them promising targets for therapeutic interventions in diseases like pemphigus, where dysregulated cell death and immune responses are pivotal. The gene discussed is XBP1; the disease is pemphigus.